A recent study has found that the phosphorylation site of 4E-BP1 is a possible prognosis predictor in patients with NSCLC, in which enhanced p-4E-BP1 Thr70 expression was highly correlated with low survival rates [30]. The gene discussed is EIF4EBP1; the disease is non-small cell lung carcinoma.